10x Genomics Pre-Tax Profit Margin 2018-2025 | TXG
10x Genomics pre-tax profit margin from 2018 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| 10x Genomics Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-09-30 | $0.64B | $-0.07B | -11.37% |
| 2025-06-30 | $0.65B | $-0.08B | -12.25% |
| 2025-03-31 | $0.63B | $-0.15B | -24.48% |
| 2024-12-31 | $0.61B | $-0.18B | -28.97% |
| 2024-09-30 | $0.63B | $-0.18B | -27.94% |
| 2024-06-30 | $0.63B | $-0.23B | -37.03% |
| 2024-03-31 | $0.63B | $-0.26B | -41.21% |
| 2023-12-31 | $0.62B | $-0.25B | -40.39% |
| 2023-09-30 | $0.59B | $-0.22B | -37.06% |
| 2023-06-30 | $0.57B | $-0.17B | -29.40% |
| 2023-03-31 | $0.54B | $-0.17B | -31.72% |
| 2022-12-31 | $0.52B | $-0.16B | -31.40% |
| 2022-09-30 | $0.50B | $-0.16B | -32.14% |
| 2022-06-30 | $0.50B | $-0.14B | -27.91% |
| 2022-03-31 | $0.50B | $-0.09B | -17.03% |
| 2021-12-31 | $0.49B | $-0.05B | -11.00% |
| 2021-09-30 | $0.46B | $-0.45B | -97.39% |
| 2021-06-30 | $0.41B | $-0.50B | -121.92% |
| 2021-03-31 | $0.33B | $-0.53B | -157.66% |
| 2020-12-31 | $0.30B | $-0.54B | -178.93% |
| 2020-09-30 | $0.26B | $-0.13B | -50.76% |
| 2020-06-30 | $0.25B | $-0.08B | -31.08% |
| 2020-03-31 | $0.26B | $-0.05B | -18.56% |
| 2019-12-31 | $0.25B | $-0.03B | -13.01% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $2.126B | $0.611B |
| 10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California. | |||